Decreased INPP4B expression was associated with triple-negative breast cancers, and notably increased INPP4B expression was demonstrated in 25% of breast cancers associated with ER/PR-positivity and the luminal subtype (Fig. 1c, d and Supplementary Fig. 1d,,  e). Here, ESR1 is linked to triple-negative breast carcinoma.